Zalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., . . . Bigner, D. D. (2007). Clinical Experience with α-Particle–Emitting (211)At: Treatment of Recurrent Brain Tumor Patients with (211)At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6.
Chicago-tyylinen lähdeviittausZalutsky, Michael R., David A. Reardon, Gamal Akabani, R. Edward Coleman, Allan H. Friedman, Henry S. Friedman, Roger E. McLendon, Terence Z. Wong, ja Darell D. Bigner. Clinical Experience With α-Particle–Emitting (211)At: Treatment of Recurrent Brain Tumor Patients With (211)At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6. 2007.
MLA-viiteZalutsky, Michael R., et al. Clinical Experience With α-Particle–Emitting (211)At: Treatment of Recurrent Brain Tumor Patients With (211)At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6. 2007.